Virginie Blanvillain Rivera

Virginie Blanvillain Rivera

Company: MicroSintesis

Job title: Clinical Research Manager


Understanding Microbiome Therapies, a New Approach to Solving Dysbiosis-Related Challenges as an Alternative to Antibiotic Treatment 1:30 pm

•Proteobiotics contain targeted groups of biopeptides that have the ability to disrupt quorum sensing and virulence gene expression of pathogens such as E.coli and Clostridium perfringens • In-water administration of proteobiotics to broilers challenged on Clostridium perfringens showed a significant reduction in necroticrelated mortality from 24.7% to 13.5% • In-water administration of proteobiotics to piglets…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.